Sakar Healthcare Dividends and Buybacks
Dividend criteria checks 0/6
Sakar Healthcare does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-2.5%
Buyback Yield
| Total Shareholder Yield | -2.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think
Oct 30
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?
Dec 28Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?
Aug 05Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?
Mar 29Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors
Jan 31Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?
Dec 01Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet
Jul 13Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet
Mar 26With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting
Jul 01Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today
Mar 23Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares
Mar 02Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Feb 08Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?
Jan 10Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock
Dec 14Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?
Nov 22
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SAKAR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SAKAR's dividend payments have been increasing.
Dividend Yield vs Market
| Sakar Healthcare Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SAKAR) | n/a |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.2% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (SAKAR) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate SAKAR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SAKAR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SAKAR's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SAKAR has not reported any payouts.